X0303 4 2010-11-08 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001479927 Chouinard Michel 7150 MISSISSAUGA ROAD MISSISSAUGA A6 L5N 8M5 ONTARIO, CANADA 0 1 0 0 COO, Biovail Labs. Intl SRL Common Shares, no par value 2010-11-08 4 M 0 102658 0 A 105128 D Restricted Share Units 2010-11-08 4 M 0 51329 D 2010-11-08 2014-08-05 Common Shares, no par value 51329 0 D Each Restricted Share Unit ("RSU") represents a contingent right to receive one common share, no par value, of Valeant Pharmaceuticals International, Inc. and is subject to performance based vesting criteria, providing for vesting ranging from zero (0) to two hundred percent (200%). Represents performance based RSUs that accelerated at 200% in connection with the merger between the issuer (formerly known as Biovail Corporation) and Valeant Pharmaceuticals International and vested following the completion of the issuer's blackout period restrictions on November 8, 2010. By: Angie Palmer For: Michel Chouinard 2010-11-10